Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the ...

Omeros (OMER) reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart ...

To facilitate quantitative evaluation of deployed devices, a novel algorithm is presented that generates intuitive two-dimensional representations of wall apposition from either high-resolution ...

The Javelin IVL catheter "has the ability to transform the way that physicians are able to treat patients,” Shockwave CMO Dr. Nick West said.

(MENAFN- EIN Presswire) BOTHELL, WA, UNITED STATES, March 11, 2025 /EINPresswire / -- VerAvanti, a deep tech company focused on intravascular imaging technology, is pleased to announce the successful ...

These findings, combined with the clinical and medical history, confirmed the diagnosis of IVL. Clinical manifestations and imaging findings of intravascular leiomyomatosis (IVL) are often ...

Based on laboratory findings and the pathological assessment of bone marrow and random skin biopsies, the patient was diagnosed with intravascular lymphoma (IVL). Persistent hyperintense lesions on ...

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

The the Court of Justice for the European Union reports a decrease in new IP cases in 2024 despite a 12% increase in overall ...

Boston Scientific is acquiring SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a current equity stake of nearly 10% in SoniVie, Boston Scientific's transaction ...